Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway |
| |
| Authors: | Jiahui Yuan Gongye Zhang Xiaomei Li Qiujuan Ma Weipeng Cheng Weiwei Wang Bing Zhang Tianhui Hu Gang Song |
| |
| Affiliation: | 1.Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361102, China; (J.Y.); (G.Z.); (X.L.); (Q.M.); (W.C.); (W.W.); (T.H.);2.Department of Basic Medicine, School of Medicine, Xiamen University, Xiamen 361102, China; |
| |
| Abstract: | Ubiquitin-specific protease 39 (USP39), a member of the deubiquitinating enzyme family, has been reported to participate in cytokinesis and metastasis. Previous studies determined that USP39 functions as an oncogenic factor in various types of cancer. Here, we reported that USP39 is frequently overexpressed in human lung cancer tissues and non-small-cell lung cancer (NSCLC) cell lines. USP39 knockdown inhibited the proliferation and colony formation of A549 and HCC827 cells and decreased tumorigenic potential in nude mice. Specifically, knocking down USP39 resulted in cell cycle arrest at G2/M and subsequent apoptosis through the activation of the p53 pathway, including upregulation of p21, cleaved-cas3, cleaved-cas9 and downregulation of CDC2 and CycinB1. Moreover, USP39 knockdown significantly inhibited migration and invasion of A549 and HCC827 cells, also via activation of the p53 pathway, and downregulation of MMP2 and MMP9. Importantly, we verified these results in metastasis models in vivo. Collectively, these results not only establish that USP39 functions as an oncogene in lung cancer, but reveal that USP39 has an essential role in regulating cell proliferation and metastasis via activation of the p53 pathway. |
| |
| Keywords: | USP39 proliferation growth metastasis p53 pathway |
|
|
